Table 2.

Trimethoprim–sulfamethoxazole risk score.

Patient-Specific Characteristic	Points
TMP-SMX use in past 12 months	1
Prior urine cultures with TMP-SMX-resistant pathogen in past 12 months	2
TMP-SMX Risk Score Interpretation Score < 1 implies < 13% predicted probability of TMP-SMX resistance Score ≥ 1 implies > 30% predicted probability of TMP-SMX resistance
May utilize local validated risk scores if applicable with corresponding risk cutoffs
Adapted from [20]